Impaired renal autoregulation and pressure-natriuresis: any role in the development of heart failure in normotensive and angiotensin II-dependent hypertensive rats?

被引:0
|
作者
Zuzana Honetschlägerová
Janusz Sadowski
Elzbieta Kompanowska-Jezierska
Hana Maxová
Miloš Táborský
Petr Kujal
Luděk Červenka
机构
[1] Institute for Clinical and Experimental Medicine,Center for Experimental Medicine
[2] Mossakowski Medical Research Institute,Department of Renal and Body Fluid Physiology
[3] Polish Academy of Sciences,Department of Pathophysiology, 2nd Faculty of Medicine
[4] Charles University,Department of Internal Medicine I, Cardiology
[5] University Hospital Olomouc and Palacký University,Department of Pathology, 3rd Faculty of Medicine
[6] Charles University,undefined
来源
Hypertension Research | 2023年 / 46卷
关键词
Volume-overload heart failure; Ren-2 transgenic hypertensive rat; Renal autoregulation; Renal blood flow; Sodium excretion;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the present study was to assess the autoregulatory capacity of renal blood flow (RBF) and of the pressure-natriuresis characteristics in the early phase of heart failure (HF) in rats, normotensive and with angiotensin II (ANG II)-dependent hypertension. Ren-2 transgenic rats (TGR) were employed as a model of ANG II-dependent hypertension. HF was induced by creating the aorto-caval fistula (ACF). One week after ACF creation or sham-operation, the animals were prepared for studies evaluating in vivo RBF autoregulatory capacity and the pressure-natriuresis characteristics after stepwise changes in renal arterial pressure (RAP) induced by aortic clamping. In ACF TGR the basal mean arterial pressure, RBF, urine flow (UF), and absolute sodium excretion (UNaV) were all significantly lower tha n in sham-operated TGR. In the latter, reductions in renal arterial pressure (RAP) significantly decreased RBF whereas in ACF TGR they did not change. Stepwise reductions in RAP resulted in marked decreases in UF and UNaV in sham-operated as well as in ACF TGR, however, these decreases were significantly greater in the former. Our data show that compared with sham-operated TGR, ACF TGR displayed well-maintained RBF autoregulatory capacity and improved slope of the pressure-natriuresis relationship. Thus, even though in the very early HF stage renal dysfunction was demonstrable, in the HF model of ANG II-dependent hypertensive rat such dysfunction and the subsequent HF decompensation cannot be simply ascribed to impaired renal autoregulation and pressure-natriuresis relationship.
引用
收藏
页码:2340 / 2355
页数:15
相关论文
共 9 条
  • [1] Impaired renal autoregulation and pressure-natriuresis: any role in the development of heart failure in normotensive and angiotensin II-dependent hypertensive rats?
    Honetschlagerova, Zuzana
    Sadowski, Janusz
    Kompanowska-Jezierska, Elzbieta
    Maxova, Hana
    Taborsky, Milos
    Kujal, Petr
    Cervenka, Ludek
    HYPERTENSION RESEARCH, 2023, 46 (10) : 2340 - 2355
  • [2] Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats
    Wang, CT
    Chin, SY
    Navar, LG
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (02) : F319 - F325
  • [3] Gender Differences in Pressure-Natriuresis and Renal Autoregulation Role of the Angiotensin Type 2 Receptor
    Hilliard, Lucinda M.
    Nematbakhsh, Mehdi
    Kett, Michelle M.
    Teichman, Elleesha
    Sampson, Amanda K.
    Widdop, Robert E.
    Evans, Roger G.
    Denton, Kate M.
    HYPERTENSION, 2011, 57 (02) : 275 - 282
  • [4] Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure
    Vackova, Sarka
    Kikerlova, Sona
    Melenovsky, Vojtech
    Kolar, Frantisek
    Imig, John D.
    Kompanowska-Jezierska, Elzbieta
    Sadowski, Janusz
    Cervenka, Ludek
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (04) : 792 - 809
  • [5] Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats
    Erbanova, Michaela
    Thumova, Monika
    Huskova, Zuzana
    Vaneckova, Ivana
    Vanourkova, Zdenka
    Mullins, John J.
    Kramer, Herbert J.
    Buergelova, Marcela
    Rakusan, Dan
    Cervenka, Ludek
    JOURNAL OF HYPERTENSION, 2009, 27 (03) : 575 - 586
  • [6] Renal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula
    Honetschlagerova, Zuzana
    Gawrys, Olga
    Jichova, Sarka
    Skaroupkova, Petra
    Kikerlova, Sona
    Vanourkova, Zdenka
    Huskova, Zuzana
    Melenovsky, Vojtech
    Kompanowska-Jezierska, Elzbieta
    Sadowski, Janusz
    Kolar, Frantisek
    Novotny, Jiri
    Hejnova, Lucie
    Kujal, Petr
    Cervenka, Ludek
    KIDNEY & BLOOD PRESSURE RESEARCH, 2021, 46 (01) : 95 - 113
  • [7] Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension
    Kala, Petr
    Gawrys, Olga
    Miklovic, Matus
    Vanourkova, Zdenka
    Skaroupkova, Petra
    Jichova, Sarka
    Sadowski, Janusz
    Kompanowska-Jezierska, Elzbieta
    Walkowska, Agnieszka
    Veselka, Josef
    Taborsky, Milos
    Maxova, Hana
    Vaneckova, Ivana
    Cervenka, Ludek
    JOURNAL OF HYPERTENSION, 2023, 41 (01) : 99 - 114
  • [8] Role of chymase in blood pressure control, plasma and tissue angiotensin II, renal Haemodynamics, and excretion in spontaneously hypertensive rats
    Roszkowska-Chojecka, Malwina M.
    Baranowska, Iwona
    Gawrys, Olga
    Sadowski, Janusz
    Walkowska, Agnieszka
    Kalisz, Malgorzata
    Litwiniuk, Anna
    Kompanowska-Jezierska, Elzbieta
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2021, 43 (05) : 392 - 401
  • [9] ROLE OF MAS RECEPTOR ANTAGONIST (A779) ON PRESSURE DIURESIS AND NATRIURESIS AND RENAL BLOOD FLOW IN THE ABSENCE OF ANGIOTENSIN II RECEPTORS TYPE 1 AND 2 IN FEMALE AND MALE RATS
    Mansoori, A.
    Oryan, S.
    Nematbakesh, M.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2014, 65 (05): : 633 - 639